GlassScriptPhysician profile
Shalin Shakya
NPI 1548573173
$2,893.93
in general payments reported to CMS, 2019-2025
15 companies · $268 in 2025
The $268 reported for 2025 was more than what 81% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.98 · 2020: $98.77 · 2021: $1,298 · 2022: $742 · 2023: $457 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $1,055.57 | 2021-2023 | Nuzyra |
| Astrazeneca Pharmaceuticals LP | $437.31 | 2021-2023 | Lokelma |
| Janssen Pharmaceuticals, INC | $317.33 | 2019-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $248.94 | 2021 | |
| La Jolla Pharmaceutical Company | $211.94 | 2021-2022 | |
| Madrigal Pharmaceuticals | $136.03 | 2025 | Rezdiffra |
| Beta Bionics, INC. | $131.57 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Novartis Pharmaceuticals Corporation | $123.26 | 2021-2022 | |
| Melinta Therapeutics, LLC | $55.29 | 2021 | |
| Vifor Pharma, INC. | $47.49 | 2021-2022 | |
| Abbvie INC. | $39.40 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.45 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.03 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.66 | 2021 | |
| Mylan Specialty L.P. | $17.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shalin Shakya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.